Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent Lai

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Molecular Therapy. Methods & Clinical Development|February 14, 2024
Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of GalactosemiaBijina Balakrishnan, Xinhua Yan, Marshall D McCue, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PGM1 deficiency disrupts sarcomere and mitochondrial function in a stem-cell cardiomyocyte modelSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Journal of Translational Medicine|February 21, 2026
PGM1 deficiency is linked to sarcomeric and mitochondrial dysfunction in patient-derived iPSC-cardiomyocytesSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2015
Structure activity relationships of human galactokinase inhibitorsLi Liu, Manshu Tang, Martin J Walsh, et al.
Molecular Genetics and Metabolism|January 20, 2020
The Galactose Index measured in fibroblasts of GALT deficient patients distinguishes variant patients detected by newborn screening from patients with classical phenotypesMendy M Welsink-Karssies, Michel van Weeghel, Carla E M Hollak, et al.
Journal of Medicinal Chemistry|September 7, 2021
Structure-Based Optimization of Small Molecule Human Galactokinase InhibitorsLi Liu, Manshu Tang, Rajan Pragani, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Molecular Therapy. Methods & Clinical Development|February 14, 2024
Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of GalactosemiaBijina Balakrishnan, Xinhua Yan, Marshall D McCue, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PGM1 deficiency disrupts sarcomere and mitochondrial function in a stem-cell cardiomyocyte modelSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Journal of Translational Medicine|February 21, 2026
PGM1 deficiency is linked to sarcomeric and mitochondrial dysfunction in patient-derived iPSC-cardiomyocytesSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2015
Structure activity relationships of human galactokinase inhibitorsLi Liu, Manshu Tang, Martin J Walsh, et al.
Molecular Genetics and Metabolism|January 20, 2020
The Galactose Index measured in fibroblasts of GALT deficient patients distinguishes variant patients detected by newborn screening from patients with classical phenotypesMendy M Welsink-Karssies, Michel van Weeghel, Carla E M Hollak, et al.
Journal of Medicinal Chemistry|September 7, 2021
Structure-Based Optimization of Small Molecule Human Galactokinase InhibitorsLi Liu, Manshu Tang, Rajan Pragani, et al.
Pageof 5